COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 917: Articles 9161-9170  | Next

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
Greaney, A. J., Eguia, R. T., Starr, T. N., Khan, K., Franko, N., Logue, J. K., Lord, S. M., Speake, C., Chu, H. Y., Sigal, A., Bloom, J. D.
10.1101/2022.03.12.484088 — Posted: 2022-03-14
Discovery of anti-SARS-CoV-2 molecules using structure-assisted repurposing approach targeting N-protein
Dhaka, P., Singh, A., Choudhary, S., Kumar, P., Sharma, G. K., Tomar, S.
10.1101/2022.03.12.484092 — Posted: 2022-03-14
Dual inhibition of vacuolar ATPase and TMPRSS2 is required for complete blockade of SARS-CoV-2 entry into cells
Icho, S., Rujas, E., Muthuraman, K., Tam, J., Liang, H., Harms, S., Liao, M., Falzarano, D., Julien, J.-P., Melnyk, R.
10.1101/2022.03.11.484006 — Posted: 2022-03-14
Migrants' primary care utilisation before and during the COVID-19 pandemic in England: An interrupted time series
Zhang, C. X., Boukari, Y., Pathak, N., Mathur, R., Katikireddi, S. V., Patel, P., Campos-Matos, I., Lewer, D., Nguyen, V., Hugenholtz, G., Burns, R., Mulick, A. R., Henderson, A., Aldridge, R. W.
10.1101/2022.03.14.22272283 — Posted: 2022-03-14
Acidity of expiratory aerosols controls the infectivity of airborne influenza virus and SARS-CoV-2
Luo, B., Schaub, A., Glas, I., Klein, L. K., David, S. C., Bluvshtein, N., Violaki, K., Motos, G., Pohl, M., Hugentobler, W., Nenes, A., Krieger, U. K., Stertz, S., Peter, T., Kohn, T.
10.1101/2022.03.14.22272134 — Posted: 2022-03-14
Molecular docking between human TMPRSS2 and the serine protease Kunitz-type inhibitor rBmTI-A
Bomediano-Camillo, L. d. M., Sasaki, S. D.
10.1101/2022.03.13.484191 — Posted: 2022-03-14
Parsing the role of NSP1 in SARS-CoV-2 infection
Fisher, T., Gluck, A., Narayanan, K., Kuroda, M., Nachshon, A., C Hsu, J., J Halfmann, P., Yahalom-Ronen, Y., Finkel, Y., Schwartz, M., Weiss, S., K Tseng, C.-T., Israely, T., Paran, N., Kawaoka, Y., Makino, S., Sternn-Ginnosar, N.
10.1101/2022.03.14.484208 — Posted: 2022-03-14
Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmission
Ye, C., Park, J.-G., Chiem, K., Dravid, P., Allue Guardia, A., Garcia-Vilanova, A., kapoor, A., Walter, M. R., Kobie, J., Plemper, R. K., Torrelles, J. B., Martinez-Sobrido, L.
10.1101/2022.03.13.484172 — Posted: 2022-03-14
Lower Risk of Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) with the Delta variant of SARS-CoV-2
Cohen, J. M., Ladhani, S., Carter, M. J., Cheung, R., Evelina PIMS-TS Study Group
10.1101/2022.03.13.22272267 — Posted: 2022-03-14
Broad Cross-reactive IgA and IgG Against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection
Wang JIong, J., Young, B. E., Li, D., Seppo, A. E., Zhou, Q., Wiltse, A., Nowak-wegrzyn, A., Murphy, K., Widrick, K., Diaz, N., CruzVasquez, J., Jarvinen, K. M., Zand, M. S.
10.1101/2022.03.13.22272281 — Posted: 2022-03-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).